Cargando…

A novel fully human monoclonal antibody that neutralizes multiple human IFN-α subtypes effectively: a candidate therapy for SLE

Detalles Bibliográficos
Autores principales:	Wang, Shuang, Du, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649421/ http://dx.doi.org/10.1186/2051-1426-3-S2-P240

Ejemplares similares

In silico prediction of the neutralization range of human anti-HIV monoclonal antibodies
por: Shmelkov, E, et al.
Publicado: (2012)

P04-55 LB. Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes
por: Zolla-Pazner, S, et al.
Publicado: (2009)

Fully Human Monoclonal Antibodies Effectively Neutralizing Botulinum Neurotoxin Serotype B
por: Matsumura, Takuhiro, et al.
Publicado: (2020)

Lower toxicity and higher efficacy: a study on a novel fully human anti-EGFR antibody
por: Qiu, Weiyi, et al.
Publicado: (2015)

P04-10. Neutralization of Tier 1 and Tier 2 pseudoviruses by human anti-V3 monoclonal antibodies
por: Gorny, MK, et al.
Publicado: (2009)

Structural Insights into the Neutralization Properties of the Fully Human, Anti-interferon Monoclonal Antibody Sifalimumab
por: Oganesyan, Vaheh, et al.
Publicado: (2015)

P04-27. Monoclonal neutralizing antibodies inhibit HIV-1 transfer from immature dendritic cells to human primary CD4 T-lymphocytes
por: Xu, K, et al.
Publicado: (2009)

Neutralizing antibodies in humans infected with zoonotic simian foamy viruses
por: Lambert, Caroline A, et al.
Publicado: (2015)

IFNα Inducible Models of Murine SLE
por: Liu, Zheng, et al.
Publicado: (2013)

Neutralizing and non-neutralizing antibody responses in HIV-1 subtype C chronically infected patients with divergent rates of disease progression
por: Archary, D, et al.
Publicado: (2012)

Antirheumatic effects of humanized anti-Fas monoclonal antibody in human rheumatoid arthritis/SCID mouse chimera
por: Matsuno, H, et al.
Publicado: (2003)

HIV-1 neutralizing antibodies display dual specificity for the primary and coreceptor binding sites and preferential recognition of fully-cleaved Env
por: Li, Y, et al.
Publicado: (2012)

Characterizing the fitness cost of viral escape from the HIV-1 broadly neutralizing monoclonal antibody VRC01
por: Lynch, RM, et al.
Publicado: (2012)

Fully human anti-macrophage migration inhibitory factor antibodies as potential therapeutics for sepsis and septic shock
por: Kerschbaumer, Randolf, et al.
Publicado: (2008)

Superinfection by discordant subtypes of HIV-1 does not enhance the neutralizing antibody response against autologous virus
por: Mayr, LM, et al.
Publicado: (2012)

A case with SLE and Pseudohypoparathyreoidism
por: Varbanova, B, et al.
Publicado: (2008)

Biodistribution of neutralizing monoclonal antibodies IgG1 b12 and LALA in mucosal and lymphatic tissues of rhesus macaques
por: Hessell, AJ, et al.
Publicado: (2012)

A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes
por: Clementi, Nicola, et al.
Publicado: (2011)

P04-22. Multispecific monoclonal antibodies bind to primary human macrophages and induce the production of protective chemokines, MIP-1α and MIP-1β
por: Weaver, KL, et al.
Publicado: (2009)

A fully human neutralizing monoclonal antibody targeting a highly conserved epitope of the human cytomegalovirus glycoprotein B
por: Okamoto, Miwa, et al.
Publicado: (2023)

V5 region in the HIV-1 envelope glycoprotein determines viral sensitivity to the broadly neutralizing monoclonal antibody VRC01
por: Guo, D, et al.
Publicado: (2012)

Monoclonal Antibodies for Systemic Lupus Erythematosus (SLE) †
por: Ponticelli, Claudio, et al.
Publicado: (2010)

Comparison of the neutralization sensitivity of South African and Indian HIV-1 subtype C viruses to South African plasma antibodies
por: Hermanus, T, et al.
Publicado: (2012)

In vitro characterization of AA71, a potent and selective human monoclonal antibody against CGRP receptor
por: Shi, L, et al.
Publicado: (2013)

Antagonist properties of monoclonal antibodies to human CD28: role of valency and heavy-chain constant domain
por: Mary, Caroline, et al.
Publicado: (2012)

Identification of the antigen recognized by rHIgM22, a remyelination-promoting human monoclonal antibody
por: Grassi, Sara, et al.
Publicado: (2015)

Impact of IgA constant domain on HIV-1 neutralizing function of monoclonal antibody F425-A1g8
por: Yu, X, et al.
Publicado: (2012)

Organ system-involvement in SLE and relationship with demographic factors, disease duration and health-related quality of life in childhood SLE
por: Moorthy, Lakshmi N, et al.
Publicado: (2012)

Neutralizing anti-HIV antibodies develop in a humanized mouse model of HIV-1 infection
por: Seung, E, et al.
Publicado: (2012)

S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-α) monoclonal antibody as a candidate treatment for selected autoimmune rheumatic diseases
por: Duguet, Fanny, et al.
Publicado: (2021)

Sequential exposure to specific antibody escape mutations may program neutralization breadth during subtype A HIV-1 infection
por: Murphy, MK, et al.
Publicado: (2012)

Characterization of conformation-specific, human-derived monoclonal antibodies against TTR aggregates with potential for diagnostic and therapeutic use
por: Michalon, Aubin, et al.
Publicado: (2015)

Use of Rituximab in child with SLE and myocardial involvement
por: Balan, S, et al.
Publicado: (2008)

Two different cases of SLE with neuropsychiatric manifestation
por: Panaviene, V, et al.
Publicado: (2011)

Lack of association of hepatitis C virus (HCV) antibodies and juvenile onset systemic lupus erythematosus (jSLE)
por: Goldenstein-Schainberg, Cláudia, et al.
Publicado: (2011)

IFN-α(2b) reduces released particles of Human T-lymphotropic Virus-I from HTLV-I transformed cell line
por: Hartoonian, Christine, et al.
Publicado: (2011)

Cross-clade neutralization of HIV-1 by a monoclonal antibody obtained by immunization with liposomes containing lipid A and a synthetic MPER peptide
por: Matyas, GR, et al.
Publicado: (2012)

Immunotherapy of SARS based on combinations of neutralizing human monoclonal antibodies
por: Du, Lanying, et al.
Publicado: (2010)

Novel monoclonal antibodies against pathogenic Leptospira
por: de Matos, Bruno Moisés, et al.
Publicado: (2014)

Broad and potent neutralization of HIV-1 by human-llama fusion antibodies derived from immunized llamas
por: McCoy, LE, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_evmbtbb2rognep94u8ern67beg